AgomAb Therapeutics NV (AGMB)

Last Closing Price: 13.73 (2026-08-18)

Debt to Equity Ratio (Quarterly)

Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity

AgomAb Therapeutics NV (AGMB) Debt to Equity Ratio data is not available.

Figures for fiscal quarter ending 2026-06-30
Income Statement Financials
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
Balance Sheet Financials
$300.54M
$0.52M
$37.72M
$338.26M
$23.34M
$1.06M
$6.37M
$29.70M
$308.55M
$275.16M
$308.55M
--
Cash Flow Statement Financials
$-34.78M
--
$191.95M
$100.48M
$257.64M
$157.16M
$2.87M
--
--
Fundamental Metrics & Ratios
--
--
--
--
Debt to Equity Ratio
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--